|
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | 162 Months Ended | ||||
|---|---|---|---|---|---|---|
|
Mar. 31, 2014
|
Mar. 31, 2013
|
Mar. 31, 2014
|
||||
| Operating costs and expenses: | ||||||
| Research and development, net | $ 680 | $ 522 | $ 29,786 | |||
| General and administrative | 351 | 559 | 21,203 | |||
| Total operating costs and expenses | 1,031 | 1,081 | 50,989 | |||
| Financial expenses (income), net | 1,080 | 1 | 3,390 | |||
| Other income | 0 | 0 | (132) | |||
| Operating loss | 2,111 | 1,082 | 54,247 | |||
| Taxes on income | 0 | 0 | 107 | |||
| Loss from continuing operations | 2,111 | 1,082 | 54,354 | |||
| Net loss from discontinued operations | 0 | 0 | 164 | [1] | ||
| Net loss | $ 2,111 | $ 1,082 | $ 54,518 | [1] | ||
| Basic and diluted net loss per share from continuing operations (in dollars per share) | $ 0.01 | $ 0.01 | ||||
| Weighted average number of shares outstanding used in computing basic and diluted net loss per share (in shares) | 176,305,587 | 150,953,117 | ||||
|
||||||